Literature DB >> 22378926

A biophysical indicator of vaso-occlusive risk in sickle cell disease.

David K Wood1, Alicia Soriano, L Mahadevan, John M Higgins, Sangeeta N Bhatia.   

Abstract

The search for predictive indicators of disease has largely focused on molecular markers. However, biophysical markers, which can integrate multiple pathways, may provide a more global picture of pathophysiology. Sickle cell disease affects millions of people worldwide and has been studied intensely at the molecular, cellular, tissue, and organismal level for a century, but there are still few, if any, markers quantifying the severity of this disease. Because the complications of sickle cell disease are largely due to vaso-occlusive events, we hypothesized that a physical metric characterizing the vaso-occlusive process could serve as an indicator of disease severity. Here, we use a microfluidic device to characterize the dynamics of "jamming," or vaso-occlusion, in physiologically relevant conditions, by measuring a biophysical parameter that quantifies the rate of change of the resistance to flow after a sudden deoxygenation event. Our studies show that this single biophysical parameter could be used to distinguish patients with poor outcomes from those with good outcomes, unlike existing laboratory tests. This biophysical indicator could therefore be used to guide the timing of clinical interventions, to monitor the progression of the disease, and to measure the efficacy of drugs, transfusion, and novel small molecules in an ex vivo setting.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378926      PMCID: PMC3633235          DOI: 10.1126/scitranslmed.3002738

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  51 in total

1.  Next-generation biomarkers for detecting kidney toxicity.

Authors:  Joseph V Bonventre; Vishal S Vaidya; Robert Schmouder; Peter Feig; Frank Dieterle
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

Review 2.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

Review 3.  Hemoglobin research and the origins of molecular medicine.

Authors:  Alan N Schechter
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

Review 4.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 5.  Pathogenesis and treatment of sickle cell disease.

Authors:  H F Bunn
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

Review 6.  Hemoglobin S gelation and sickle cell disease.

Authors:  W A Eaton; J Hofrichter
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

7.  Alzheimer's biomarker initiative hits its stride.

Authors:  Greg Miller
Journal:  Science       Date:  2009-10-16       Impact factor: 47.728

Review 8.  Common markers of proliferation.

Authors:  Michael L Whitfield; Lacy K George; Gavin D Grant; Charles M Perou
Journal:  Nat Rev Cancer       Date:  2006-02       Impact factor: 60.716

Review 9.  Sickle cell disease and stroke.

Authors:  Luis A Verduzco; David G Nathan
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

Review 10.  Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches.

Authors:  Martin H Steinberg
Journal:  ScientificWorldJournal       Date:  2008-12-25
View more
  48 in total

1.  Microfluidic chips promise better diagnosis for sickle cell disease.

Authors:  Rebecca Hersher
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

2.  Electrical impedance microflow cytometry with oxygen control for detection of sickle cells.

Authors:  Jia Liu; Yuhao Qiang; Ofelia Alvarez; E Du
Journal:  Sens Actuators B Chem       Date:  2017-08-24       Impact factor: 7.460

3.  Quantitative microfluidic fluorescence microscopy to study vaso-occlusion in sickle cell disease.

Authors:  Maritza A Jimenez; Egemen Tutuncuoglu; Suchitra Barge; Enrico M Novelli; Prithu Sundd
Journal:  Haematologica       Date:  2015-05-14       Impact factor: 9.941

Review 4.  Biomechanical properties of red blood cells in health and disease towards microfluidics.

Authors:  Giovanna Tomaiuolo
Journal:  Biomicrofluidics       Date:  2014-09-17       Impact factor: 2.800

5.  Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis.

Authors:  E Du; Monica Diez-Silva; Gregory J Kato; Ming Dao; Subra Suresh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 6.  Micro total analysis systems: fundamental advances and applications in the laboratory, clinic, and field.

Authors:  Michelle L Kovarik; Douglas M Ornoff; Adam T Melvin; Nicholas C Dobes; Yuli Wang; Alexandra J Dickinson; Philip C Gach; Pavak K Shah; Nancy L Allbritton
Journal:  Anal Chem       Date:  2012-12-04       Impact factor: 6.986

7.  The physical foundation of vasoocclusion in sickle cell disease.

Authors:  Alexey Aprelev; William Stephenson; Hongseok Moses Noh; Maureen Meier; Frank A Ferrone
Journal:  Biophys J       Date:  2012-10-16       Impact factor: 4.033

8.  Exogenous sickle erythrocytes combined with vascular disruption trigger disseminated tumor vaso-occlusion and lung tumor regression.

Authors:  Chiao-Wang Sun; Li-Chen Wu; Mamta Wankhede; Dezhi Wang; Jutta Thoerner; Lawrence Woody; Brian S Sorg; Tim M Townes; David S Terman
Journal:  JCI Insight       Date:  2019-02-19

9.  Microfluidic organs-on-chips.

Authors:  Sangeeta N Bhatia; Donald E Ingber
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

Review 10.  The present and future role of microfluidics in biomedical research.

Authors:  Eric K Sackmann; Anna L Fulton; David J Beebe
Journal:  Nature       Date:  2014-03-13       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.